The Journal of Steroid Biochemistry and Molecular Biology
Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3β-hydroxysteroid dehydrogenase/Isomerase1
Introduction
Human placental 3β-hydroxysteroid dehydrogenase (3β-HSD, EC 1.1.1.145) and steroid Δ5→4-isomerase (EC 5.3.3.1) catalyze the sequential conversion of 3β-hydroxy-5-ene steroids (pregnenolone, dehydroepiandrosterone) to 3-oxo-4-ene steroids (progesterone, androstenedione) on a single, dimeric protein containing both enzyme activities[1]. The bifunctional enzyme catalyzes a key biosynthetic step that is required for each of the pathways that produce active steroid hormones. In the human, the type I enzyme (placenta, skin, mammary gland) and the type II enzyme (gonads, adrenals) are expressed in a tissue-specific pattern, are encoded by two distinct genes, and have 93% homology in the amino acid sequences[2]. The 3β-HSD and isomerase activities co-purify as the single type I protein from human term placenta1, 3.
Tryptic peptides associated with both catalytic activities have been localized using affinity radiolabeling steroids. One tryptic peptide, 250GQFYYISDDTPHQSYDNLNYTLSK273, was modified at His261 by both the 3β-HSD-site-directed alkylator, 2α-bromoacetoxyprogesterone4, 5and by the isomerase-site-directed alkylator, 5,10-secoestr-4-yne-3,10,17-trione[6]. Additional studies using stopped-flow fluorescent spectroscopy[7]supported the following model for the sequential reaction mechanism: NADH, the coenzyme product of the rate-limiting 3β-HSD reaction, induces a conformational change around the bound 3-oxo-5-ene-steroid (the 3β-HSD product and isomerase substrate) to activate isomerase in the single, bifunctional enzyme protein. Thus, 3β-HSD/isomerase offers a unique enzyme system to study using site-directed mutagenesis because an appropriately targeted point mutation may modify only one of the two activities. In the current study, we have used site-directed mutagenesis to produce three mutated forms of human type I (placental) 3β-HSD/isomerase (H261R, Y253F and Y253,254F) and compared the kinetics of the purified mutant, wild-type, and native placental enzymes to investigate the roles of the targeted amino acid residues in the 3β-HSD and isomerase reaction mechanisms.
Section snippets
Materials
Pregnenolone, dehydroepiandrosterone and pyridine nucleotides were purchased from Sigma (St. Louis, MO); 5-androstene-3,17-dione and 5-pregnene-3,20-dione from Steraloids (Wilton, NH); reagent grade salts, chemicals and analytical grade solvents from Fisher (Pittsburg, PA). Glass distilled, deionized water was used for all aqueous solutions.
Site-directed mutagenesis
The 1,555 base pair (bp) cDNA that encodes human type I (placental) 3β-HSD/isomerase was cut from the host plasmid, pCMV5H3βHSD[8], using EcoR1/PspA1 and
Expression of the mutant and wild-type enzymes
A Western blot of an SDS-polyacrylamide gel (Fig. 1) showed that Sf9 cells infected with the appropriate recombinant baculovirus expressed the immunoreactive H261R (lane 2), Y253,254F (lane 3), Y253F (lane 4) and wild type (lane 6) protein, all of which co-migrated with the purified, human placental 3β-HSD/isomerase (lane 1). The absence of a band in lane 5 shows that uninfected Sf9 cells do not express endogenous 3β-HSD/isomerase.
Kinetic analysis of the purified mutants
Table 1 summarizes the results of the substrate kinetic studies
Discussion
The 3β-HSD/isomerase enzymes present an interesting mechanistic question: Are the catalytic centers and critical amino acids for each of the two coupled, biosynthetic reactions located in unique and separate domains, in overlapping but distinct sites, or in the same, inseparable site? We have identified the active site region for 3β-HSD and isomerase in the primary structure of the enzyme using a substrate-protection technique that enhances the specificity of affinity radiolabeling steroids4, 5
References (22)
- et al.
Human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes
J. Steroid Biochem.
(1989) - et al.
Affinity radiolabeling identifies peptides and amino acids associated with substrate binding in human placental 3β-hydroxy-Δ5-steroid dehydrogenase
J. Biol. Chem.
(1993) - et al.
An NADH-induced conformational change that mediates the sequential 3β-hydroxysteroid dehydrogenase/isomerase activities is supported by affinity labeling and the time-dependent activation of isomerase
J. Biol. Chem.
(1995) - et al.
Over-expression of human type I (placental) 3β-hydroxy-5-ene-steroid dehydrogenase/isomerase in insect cells infected with recombinant baculovirus
J. Steroid Biochem. Molec. Biol.
(1994) - et al.
Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction
Gene
(1994) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding
Anal. Biochem.
(1976)- et al.
Affinity alkylation of human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase by 2α-bromoacetoxyprogesterone: evidence for separate dehydrogenase and isomerase sites on one protein
J. Steroid Biochem.
(1990) - et al.
Analysis of coenzyme binding by human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase using 5′-[p-(fluorosulfonyl)benzoyl]adenosine, an affinity labeling cofactor analog
J. Steroid Biochem. Molec. Biol.
(1991) - et al.
The key role of 17β-hydroxysteroid dehydrogenase in sex steroid biology
Steroids
(1997) - et al.
Crystal structure of Escherichia coli malate dehydrogenase. A complex of apoenzyme and citrate at 1.87 A resolution
J. Molec. Biol.
(1992)
Cited by (0)
- 1
Supported by NIH Grant HD20055 (JLT).
- 2
Present address: Department of Obstetrics and Gynecology, Henry Ford Health System, Area K-9, 2799 West Grand Boulevard, Detroit, MI 48202, U.S.A.